Centro de Imagem Diagnósticos S.A (SA:AALR3) — Market Cap & Net Worth
Market Cap & Net Worth: Centro de Imagem Diagnósticos S.A (AALR3)
Centro de Imagem Diagnósticos S.A (SA:AALR3) has a market capitalization of $91.16 Million (R$464.58 Million) as of June 19, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #19646 globally and #188 in its home market, demonstrating a -5.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Centro de Imagem Diagnósticos S.A's stock price R$3.05 by its total outstanding shares 152321877 (152.32 Million). Review AALR3 total liabilities to assess the company's total debt and financial obligations.
Centro de Imagem Diagnósticos S.A Market Cap History: 2016 to 2026
Centro de Imagem Diagnósticos S.A's market capitalization history from 2016 to 2026. Data shows change from $433.46 Million to $91.16 Million (-17.28% CAGR).
Centro de Imagem Diagnósticos S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Centro de Imagem Diagnósticos S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Centro de Imagem Diagnósticos S.A's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $433.46 Million | $951.47 Million | $14.79 Million | 0.46x | 29.30x |
| 2017 | $437.90 Million | $1.08 Billion | $6.65 Million | 0.41x | 65.83x |
| 2018 | $393.81 Million | $1.08 Billion | $40.09 Million | 0.37x | 9.82x |
| 2019 | $538.32 Million | $1.07 Billion | $41.30 Million | 0.50x | 13.03x |
| 2020 | $331.76 Million | $928.79 Million | -$97.42 Million | 0.36x | N/A |
| 2021 | $447.43 Million | $1.14 Billion | -$5.62 Million | 0.39x | N/A |
| 2022 | $645.59 Million | $1.09 Billion | -$227.81 Million | 0.60x | N/A |
| 2023 | $310.84 Million | $1.18 Billion | -$227.88 Million | 0.26x | N/A |
| 2024 | $255.54 Million | $1.22 Billion | -$129.12 Million | 0.21x | N/A |
Competitor Companies of AALR3 by Market Capitalization
Companies near Centro de Imagem Diagnósticos S.A in the global market cap rankings as of June 19, 2026.
Key companies related to Centro de Imagem Diagnósticos S.A by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #664 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #664 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Centro de Imagem Diagnósticos S.A Historical Marketcap From 2016 to 2026
Between 2016 and today, Centro de Imagem Diagnósticos S.A's market cap moved from $433.46 Million to $ 91.16 Million, with a yearly change of -17.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$91.16 Million | -39.60% |
| 2025 | R$150.94 Million | -40.94% |
| 2024 | R$255.54 Million | -17.79% |
| 2023 | R$310.84 Million | -51.85% |
| 2022 | R$645.59 Million | +44.29% |
| 2021 | R$447.43 Million | +34.86% |
| 2020 | R$331.76 Million | -38.37% |
| 2019 | R$538.32 Million | +36.69% |
| 2018 | R$393.81 Million | -10.07% |
| 2017 | R$437.90 Million | +1.02% |
| 2016 | R$433.46 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Centro de Imagem Diagnósticos S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $91.16 Million USD |
| MoneyControl | $91.16 Million USD |
| MarketWatch | $91.16 Million USD |
| marketcap.company | $91.16 Million USD |
| Reuters | $91.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Centro de Imagem Diagnósticos S.A
Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more